Technical analysis of Silence Therapeutics plc (SLN): price and volume charts, candlestick patterns, moving averages (SMA, EMA), RSI, MACD, ADX and Bollinger Bands. Identify momentum, trend direction and potential entry/exit zones.
Silence Therapeutics plc is a London, UK-based biotechnology company specializing in the research and development of groundbreaking ribonucleic acid (RNA) therapeutics. Its therapeutic focus areas include hematological, cardiovascular, and various rare and metabolic conditions. Central to their innovative approach is the mRNAi GalNAc Oligonucleotide Discovery platform, which is designed for precise targeting of specific disease-causing genes within the liver.
Price Performance
| 1 month | -11.35% |
| 3 months | +80.38% |
| Year-to-date | +105.59% |
| 1 year | +149.50% |
| 3 years | +28.47% |
| 5 years | -42.26% |
52-Week Range
| 52-week High | $17.58 |
| 52-week Low | $4.19 |
| Avg Volume (90d) | 820K |
Technical Indicators
| SMA 50 | $12.42 |
| SMA 200 | $7.91 |
| Beta | 1.33 |
| 30-day Volatility (annualised) | 90.4% |
| Price vs SMA 50 | +0.7% |
| Price vs SMA 200 | +58.0% |
Monthly Close (12 months)
| Month | Close | Change |
|---|
| 2025-10 | $7.16 | |
| 2025-11 | $6.74 | -5.9% |
| 2025-12 | $6.08 | -9.8% |
| 2026-01 | $4.82 | -20.7% |
| 2026-02 | $5.44 | +12.9% |
| 2026-03 | $5.27 | -3.1% |
| 2026-04 | $7.31 | +38.7% |
| 2026-05 | $6.90 | -5.6% |
| 2026-06 | $10.98 | +59.1% |
| 2026-07 | $10.49 | -4.5% |
| 2026-08 | $13.53 | +29.0% |
| 2026-09 | $12.50 | -7.6% |
Upcoming Earnings
| Date | EPS Est. | Revenue Est. |
|---|
| 2026-09-14 | $-2.53 | |
| 2026-09-14 | | $159M |
| 2026-09-14 | $-0.26 | $14M |
| 2026-09-14 | | |
| 2026-09-14 | $0.84 | $26M |
| 2026-09-14 | | |
Price
| Price | $12.50 |
| Market Cap | $590M |
| Exchange | NASDAQ |
| Country | GB |
Valuation Ratios
| Price / Book | 5.00 |
| EV / EBITDA | -9.01 |
| Dividend Yield | 0.00% |
Financial Health
| Debt / Equity | 0.00 |
| Current Ratio | 7.42 |